Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Histogen Inc. is declaring victory after a Southern California judge’s decision that its technique for growing human skin cells does not infringe a pair of patents covering SkinMedica’s NouriCel product line.
St. Jude Medical Inc. (NYSE:STJ) touted a regulatory win for its novel quadripolar pacing system while also warning doctors that its Riata defibrillator leads may pose a greater risk than previously reported.
Bovie Medical Corp. (NYSE:BVX) is demoting COO Moshe Citronowicz and cutting his pay and benefits after determining that he misrepresented his academic career.